TNF-Independent Development of Transient Anemia of Chronic Disease in a Mouse Model of Protracted Septic Peritonitis

Laboratory Investigation

Volumn 83, Issue 12, 2003, Pages 1743-1750

  Schubert, Thomas ^a   Echtenacher, Bernd ^a   Hofstädter, Ferdinand ^a   Männel, Daniela N ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; TUMOR NECROSIS FACTOR;

ANEMIA; ANEMIA OF CHRONIC DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DEPRESSION; CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; IN VIVO STUDY; IRON BLOOD LEVEL; IRON METABOLISM; IRON STORAGE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PERITONITIS; PRIORITY JOURNAL; PROTRACTED SEPTIC PERITONITIS;

ANEMIA; ANIMALS; ANTIBODIES, BLOCKING; BONE MARROW; CECUM; DISEASE MODELS, ANIMAL; ERYTHROCYTE COUNT; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; IRON; LIGATION; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; PERITONITIS; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0347995015     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000101693.12149.2C     Document Type: Article

References (29)

1. Akahane K, Hosoi T, Urabe A, Kawakami A, and Takaku F (1987). Effects of recombinant human tumor necrosis factor on normal and mouse hematopoietic progenitor cells. Int J Cell Clon 5:16-26.
2. Alvarez-Hernandez X, Liceaga J, McKay IC, and Brock JH (1989). Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 61:319-322.
3. Balfour Sartor R, Anderle SK, Rifai N, Goo D, Cromartie WJ, and Schwab JH (1989). Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats. Infect Immun 57:1177-1185.
4. Barrett-Connor E (1972). Anemia and infection. Am J Med 52:242-253.
5. Cartwright GE (1966). The anemia of chronic disorders. Semin Hematol 3:351-364.
6. Chang KH and Stevenson MM (2002). Comparison of murine Epo ELISA and Epo bioassays in detecting serum Epo levels during anemia associated with malaria infection. J Immunol Meth 262:129-136.
7. Davis D, Charles J, Potter A, Feldmann M, Maini RN, and Elliott MJ (1997). Anaemia of chronic disease in rheumatoid arthritis: In vivo effects of tumor necrosis factor alpha blockade. Br J Rheumatol 36:950-956.
8. Echtenacher B, Falk W, Männel DN, and Krammer PH (1990). Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 145:3762-3766.
9. Echtenacher B, Urbaschek R, Weigl K, Freudenberg MA, and Männel DN (In press, 2003). Treatment of experimental sepsis-induced immunoparalysis with TNF. Immunobiol.
10. Freireich EJ, Miller A, Emerson CP, and Ross JF (1957). The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production. Blood 12:972-981.
11. Johnson CS, Cook CA, and Furmanski P (1990). In vivo suppression of erythropoiesis by tumor necrosis factor: Reversal with exogenous erythropoietin. Exp Hematol 18:109-113.
12. Johnson RA, Waddelow TA, Caro J, Cliff A, and Roodman GD (1989). Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 74:130-138.
13. Jongen-Lavrencic M, Peeters HRM, Backx B, Touw IP, Vreugdenhil G, and Swaak AJG (1994). R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumor necrosis factor alpha in patients with rheumatoid arthritis. Rheumatol Int 14:109-113.
14. Kendall R, Wasti A, Harvey A, Hill J, Chapman C, Norfolk DR, and Pullar T (1993). The relationship of haemoglobin to serum erythropoietin concentrations in the anaemia of rheumatoid arthritis: The effect of oral prednisolone. Rheumatology 32:204-208.
15. Means RT Jr and Krantz SB (1993). Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest 91:416-430.
16. Means RT Jr, Dessypris EN, and Krantz SB (1992). Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol 150:59-71.
17. Means RT Jr, Krantz SB, Luna J, Marsters SA, and Ashkenazi A (1994). Inhibition of murine erythroid colony-formation in vitro units by interferon gamma and correction by interferon receptor immunoadhesion. Blood 83:911-915.
18. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, and Spivak JL (1990). Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689-1692.
19. Moldawer LL, Marano MA, Wei H, Fong Y, Silen ML, Kuo G, Manogue KR, Vlassara H, Cohen H, and Cerami A (1989). Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J 3:1637-1643.
20. Papadakis HA, Kritikos HD, Valatas V, Boumpas D, and Eliopoulos GD (2002). Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: Improvement following anti-tumor necrosis factor-α antibody therapy. Blood 100:474-482.
21. Pasparakis M, Alexopoulou L, Episkopou V, and Kollias G (1996). Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1207-1211.
22. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, and Munro HN (1990). Translational control during the acute phase response: Ferritin synthesis in response to interleukin-1. J Biol Chem 265:14572-14578.
23. Rusten LS and Jacobsen SEW (1995). Tumor necrosis factor directly inhibits human erythropoiesis in vitro: Role of p55 and p75 TNF receptors. Blood 85:989-996.
24. Salleri C, Maciejewski JP, Sato T, Young NS (1996). Interferon gamma constitutively expressed in the stromal micro-environment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87:4149-4164.
25. Stockenhuber F, Keil M, Wurnig C, Kurz RW, Gottsauner-Wolf M, and Balcke P (1994). Impaired erythropoietin responsiveness in anaemic rheumatoid arthritis patients: Potential relation to immune mechanisms. Clin Sci 86:633-638.
26. Vreugdenhil G, Lowenberg B, Van Eijk HG, and Swaak AJ (1992). Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Invest 22:488-493.
27. Wang CQ, Udupa KB, and Lipschitz DA (1995). Interferon gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J Cell Physiol 162:134-138.
28. Zhang Y, Harada A, Bluthmann H, Wang JB, Nakao S, Mukaida N, and Matsushima K (1995). Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: Increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF in vitro. Blood 86:2930-2937.
29. Zucker S, Friedman S, and Lysik RM (1974). Bone marrow erythropoiesis in the anemia of infection, inflammation, and malignancy. J Clin Invest 53:1132-1138.